Strickland, K. C., Wallen, Z. D., Ko, H. C., Green, M. F., Dillard, A., Pabla, S., … Previs, R. A. (2025). RB1 expression and HR proficiency define a poor-outcome molecular subtype of high grade serous ovarian carcinoma. Springer Science and Business Media LLC. https://doi.org/10.21203/rs.3.rs-5523163/v1

Strickland, Kyle C., Zachary D. Wallen, Heidi C. Ko, Michelle F. Green, Alicia Dillard, Sarabjot Pabla, Stephanie Hastings, et al. “RB1 expression and HR proficiency define a poor-outcome molecular subtype of high grade serous ovarian carcinoma.” Springer Science and Business Media LLC, July 14, 2025. https://doi.org/10.21203/rs.3.rs-5523163/v1.

Strickland KC, Wallen ZD, Ko HC, Green MF, Dillard A, Pabla S, et al. RB1 expression and HR proficiency define a poor-outcome molecular subtype of high grade serous ovarian carcinoma. Springer Science and Business Media LLC. 2025.

Strickland, Kyle C., et al. “RB1 expression and HR proficiency define a poor-outcome molecular subtype of high grade serous ovarian carcinoma.” Springer Science and Business Media LLC, 14 July 2025. Crossref, doi:10.21203/rs.3.rs-5523163/v1.

Strickland KC, Wallen ZD, Ko HC, Green MF, Dillard A, Pabla S, Hastings S, Roos A, Jensen TJ, Eisenberg M, Caveney BJ, Ramkissoon S, Severson EA, Previs RA. RB1 expression and HR proficiency define a poor-outcome molecular subtype of high grade serous ovarian carcinoma. Springer Science and Business Media LLC. 2025.